Brief: Immunocore Reports Second Quarter Financial Results And Provides A Business Update
07/08/2025 13:32
Aug 7 (Reuters) - Immunocore Holdings PLC IMCR.O: IMMUNOCORE REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE IMMUNOCORE : PHASE 3 TEBE-AM TRIAL REMAINS ON SCHEDULE TO COMPLETE ENROLLMENT IN THE FIRST HALF OF 2026 IMMUNOCORE : KIMMTRAK®(TEBENTAFUSP-TEBN) NET REVENUES OF $98.0 MILLION IN Q2 2025 Source text: ID:nGNXbVhtR1 Further company coverage: IMCR.O ((Reuters.Briefs@thomsonreuters.com;))